drugset / Trial / NCT03562949
A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the efficacy and safety profiles of Beclomethasone dipropionate Inhalation Aerosol, 40 mcg (test product) and QVAR 40 mcg (beclomethasone dipropionate HFA), Inhalation Aerosol (reference product) and to demonstrate that the efficacy of the 2 active products is superior to that of placebo in the treatment of subjects with asthma.
Timeline
- Start
- 2018-12-06
- Primary completion
- 2019-08-02
- Completion
- 2019-08-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | beclomethasone dipropionate | Other / unclassified | 40 ug | Inhaled |